Yao FY - Search Results

1

Noninvasive estimation of pulmonary vascular resistance improves portopulmonary hypertension screening in liver transplant candidates.

DesJardin JT, Manicardi M, Svetlichnaya Y, Kolaitis NA, Papolos AI, Selby VN, Zier LS, Klein L, Aras MA, Yao FY, Roberts JP, De Marco T. DesJardin JT, et al. Among authors: yao fy. Clin Transplant. 2019 Jul;33(7):e13585. doi: 10.1111/ctr.13585. Epub 2019 Jun 5. Clin Transplant. 2019. PMID: 31074522

2

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.

Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR. Yao FY, et al. Liver Transpl Surg. 1999 Nov;5(6):491-6. doi: 10.1002/lt.500050605. Liver Transpl Surg. 1999. PMID: 10545536 Free article.

3

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Yao FY, et al. Hepatology. 2001 Jun;33(6):1394-403. doi: 10.1053/jhep.2001.24563. Hepatology. 2001. PMID: 11391528

4

Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.

Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Yao FY, et al. Liver Transpl. 2002 Sep;8(9):765-74. doi: 10.1053/jlts.2002.34892. Liver Transpl. 2002. PMID: 12200775 Free article.

5

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Yao FY, et al. Liver Transpl. 2002 Oct;8(10):873-83. doi: 10.1053/jlts.2002.34923. Liver Transpl. 2002. PMID: 12360427 Free article.

6

A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.

Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP. Yao FY, et al. Liver Transpl. 2003 Jul;9(7):684-92. doi: 10.1053/jlts.2003.50147. Liver Transpl. 2003. PMID: 12827553 Free article.

7

Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.

Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Yao FY, et al. Hepatology. 2004 Jan;39(1):230-8. doi: 10.1002/hep.20005. Hepatology. 2004. PMID: 14752842

8

Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.

Yao FY, Bass NM, Ascher NL, Roberts JP. Yao FY, et al. Liver Transpl. 2004 May;10(5):621-30. doi: 10.1002/lt.20159. Liver Transpl. 2004. PMID: 15108253 Free article.

9

Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time?

Yao FY, Roberts JP. Yao FY, et al. Liver Transpl. 2004 Jul;10(7):919-21. doi: 10.1002/lt.20190. Liver Transpl. 2004. PMID: 15237378 Free article. No abstract available.

10

The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.

Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP. Yao FY, et al. Am J Transplant. 2005 Apr;5(4 Pt 1):795-804. doi: 10.1111/j.1600-6143.2005.00750.x. Am J Transplant. 2005. PMID: 15760404 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters